Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Wiesner

Showing results (361-370 of 432) with videos related to

Pageof 44
Sort By:
Transplantation Proceedings|February 1, 1993
Prognostic factors for successful conversion from cyclosporine to FK 506-based immunosuppressive therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study GroupG B Klintmalm, R Goldstein, T Gonwa, et al.
Transplantation|February 25, 1999
Human herpesvirus 6 seronegativity before transplantation predicts the occurrence of fungal infection in liver transplant recipientsD H Dockrell, J C Mendez, M Jones, et al.
Hepatology (Baltimore, Md.)|August 1, 1991
Rates of vertebral bone loss before and after liver transplantation in women with primary biliary cirrhosisR Eastell, E R Dickson, S F Hodgson, et al.
Hepatology (Baltimore, Md.)|May 5, 2000
Intragraft localization of activated nuclear factor kappaB in recurrent hepatitis C virus disease following liver transplantationA S Gaweco, R H Wiesner, M Porayko, et al.
Mayo Clinic Proceedings|July 25, 2000
A revised natural history model for primary sclerosing cholangitisW R Kim, T M Therneau, R H Wiesner, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|January 11, 2001
Natural history of vancomycin-resistant enterococcal colonization in liver and kidney transplant recipientsR Patel, S L Allen, J M Manahan, et al.
Transplantation Proceedings|February 1, 1993
Use of Prograf (FK 506) as rescue therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study GroupG B Klintmalm, R Goldstein, T Gonwa, et al.
International Journal of Technology Assessment in Health Care|October 3, 1999
Methods to estimate and analyze medical care resource use. An example from liver transplantationP P Katz, J A Showstack, J R Lake, et al.
Hepatology International|December 10, 2016
Charcoal hemoperfusion in the treatment of medically refractory pruritus in cholestatic liver diseaseWonngarm Kittanamongkolchai, Ziad M El-Zoghby, J Eileen Hay, et al.
The Journal of Infectious Diseases|February 1, 1996
Prognostic significance and risk factors of untreated cytomegalovirus viremia in liver transplant recipientsA D Badley, R Patel, D F Portela, et al.
Pageof 44

Showing results (361-370 of 432) with videos related to

Sort By:
Pageof 44
Transplantation Proceedings|February 1, 1993
Prognostic factors for successful conversion from cyclosporine to FK 506-based immunosuppressive therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study GroupG B Klintmalm, R Goldstein, T Gonwa, et al.
Transplantation|February 25, 1999
Human herpesvirus 6 seronegativity before transplantation predicts the occurrence of fungal infection in liver transplant recipientsD H Dockrell, J C Mendez, M Jones, et al.
Hepatology (Baltimore, Md.)|August 1, 1991
Rates of vertebral bone loss before and after liver transplantation in women with primary biliary cirrhosisR Eastell, E R Dickson, S F Hodgson, et al.
Hepatology (Baltimore, Md.)|May 5, 2000
Intragraft localization of activated nuclear factor kappaB in recurrent hepatitis C virus disease following liver transplantationA S Gaweco, R H Wiesner, M Porayko, et al.
Mayo Clinic Proceedings|July 25, 2000
A revised natural history model for primary sclerosing cholangitisW R Kim, T M Therneau, R H Wiesner, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|January 11, 2001
Natural history of vancomycin-resistant enterococcal colonization in liver and kidney transplant recipientsR Patel, S L Allen, J M Manahan, et al.
Transplantation Proceedings|February 1, 1993
Use of Prograf (FK 506) as rescue therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study GroupG B Klintmalm, R Goldstein, T Gonwa, et al.
International Journal of Technology Assessment in Health Care|October 3, 1999
Methods to estimate and analyze medical care resource use. An example from liver transplantationP P Katz, J A Showstack, J R Lake, et al.
Hepatology International|December 10, 2016
Charcoal hemoperfusion in the treatment of medically refractory pruritus in cholestatic liver diseaseWonngarm Kittanamongkolchai, Ziad M El-Zoghby, J Eileen Hay, et al.
The Journal of Infectious Diseases|February 1, 1996
Prognostic significance and risk factors of untreated cytomegalovirus viremia in liver transplant recipientsA D Badley, R Patel, D F Portela, et al.
Pageof 44